STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Period	fcf
2016-12-31	-$2.16M
2017-12-31	$1.81M
2018-12-31	$10.52M
2019-12-31	$15.62M
2020-12-31	$12.55M
2021-12-31	$30.32M
2022-12-31	$17.61M
2023-12-31	-$3.59M
2024-12-31	-$7.67M
2025-12-31	-$40.05M

	A	B	C	D
1	Symbol	Price	Change	Volume
2	STAA	$33.34	+2.68%	0.95M
3
4
5

STAAR Surgical Company (STAA) Free Cash Flow

Free Cash Flow Data

Get STAAR Surgical Company Data in Excel

More STAA Financial Data